Skip to main content
Top
Published in: Supportive Care in Cancer 3/2006

01-03-2006 | Original Article

Medium-term effects of chemotherapy in older cancer patients

Authors: Barbara Eberhardt, Stefan Dilger, Frauke Musial, Ulrich Wedding, Thomas Weiss, Wolfgang H. R. Miltner

Published in: Supportive Care in Cancer | Issue 3/2006

Login to get access

Abstract

Purpose

To address the lack of research in older cancer patients, the present study prospectively evaluated their cognitive functions across the first six months following diagnosis and chemotherapy.

Patients and Methods

A total of 77 younger (n=43, age < 60) and older (n=34, age ≥ 60) cancer patients with hematological disease or cancer of the intestinal tract took part in the study. Medium-term effects of chemotherapy were examined in these cancer patients by means of a battery of cognitive tests during baseline and six months after start of treatment.

Results

In contrast to baseline verbal learning, word fluency and memory capacity improved in all patients six months after start of treatment. A negative effect of age on cognitive functions could not be demonstrated. Additionally, depression was neither associated with medium-term effects of chemotherapy nor was it related to age.

Conclusion

The results suggest that chemotherapy has no negative effects on cognitive functions after the first six months following the onset of treatment. It was demonstrated that complete recovery of cognitive functions is independent of the patient’s age.
Literature
1.
go back to reference Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM (2002) Neuropsychologic impact in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493CrossRefPubMed Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, Whedon MB, Bivens S, Mitchell T, Greenberg ER, Silberfarb PM (2002) Neuropsychologic impact in long-term survivors of breast cancer and lymphoma. J Clin Oncol 20:485–493CrossRefPubMed
2.
go back to reference Aragona M, Muscatello MRA, Mestiti M (1997) Depressive mood disorders in patients with operable breast cancer. J Exp Clin Cancer Res 16:111–118PubMed Aragona M, Muscatello MRA, Mestiti M (1997) Depressive mood disorders in patients with operable breast cancer. J Exp Clin Cancer Res 16:111–118PubMed
3.
go back to reference Brezden CB, Philips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701PubMed Brezden CB, Philips KA, Abdolell M, Bunston T, Tannock IF (2000) Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 18:2695–2701PubMed
4.
go back to reference Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J (1992) Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 7:192–195CrossRefPubMed Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J (1992) Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 7:192–195CrossRefPubMed
5.
go back to reference Chibnall JT (2002) Psychosocial–spiritual correlates of death distress in patients with life-threatening medical conditions. Palliat Med 16:331–338CrossRefPubMed Chibnall JT (2002) Psychosocial–spiritual correlates of death distress in patients with life-threatening medical conditions. Palliat Med 16:331–338CrossRefPubMed
6.
7.
go back to reference Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thatcher N, Burt P, Stout R, Stepniewska K, Stewart M (1994) Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 30:1067–1074CrossRef Cull A, Gregor A, Hopwood P, Macbeth F, Karnicka-Mlodkowska H, Thatcher N, Burt P, Stout R, Stepniewska K, Stewart M (1994) Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 30:1067–1074CrossRef
8.
go back to reference Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M (1996) What do cancer patients mean when they complain of concentration and memory problems. Br J Cancer 74:1674–1679PubMed Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M (1996) What do cancer patients mean when they complain of concentration and memory problems. Br J Cancer 74:1674–1679PubMed
9.
go back to reference Eberhardt B (2003) Neuropsychologische Beeinträchtigungen bei älteren Krebspatienten. Dissertation, Jena Eberhardt B (2003) Neuropsychologische Beeinträchtigungen bei älteren Krebspatienten. Dissertation, Jena
10.
go back to reference Erzigkeit H (1992) Der SKT. Ein Kurztest zur Erfassung von Gedächtnis– und Aufmerksamkeitsstörungen. Manual. 21. Auflage. Beltz, Weinheim Erzigkeit H (1992) Der SKT. Ein Kurztest zur Erfassung von Gedächtnis– und Aufmerksamkeitsstörungen. Manual. 21. Auflage. Beltz, Weinheim
11.
go back to reference Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46:435–439PubMed Freilich RJ, Delattre JY, Monjour A, DeAngelis LM (1996) Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 46:435–439PubMed
12.
go back to reference Gallagher J, Parle M, Cairns D (2002) Appraisal and psychological distress six months after diagnosis of breast cancer. Br J Health Psychol 7:365–376CrossRefPubMed Gallagher J, Parle M, Cairns D (2002) Appraisal and psychological distress six months after diagnosis of breast cancer. Br J Health Psychol 7:365–376CrossRefPubMed
13.
go back to reference Hautzinger M, Bailer M, Worall H, Keller F (1995) Beck Depressions Inventar. Huber, Bern Hautzinger M, Bailer M, Worall H, Keller F (1995) Beck Depressions Inventar. Huber, Bern
14.
go back to reference Horn W (1983) Leistungsprüfsystem (LPS): Handanweisung. 2. überarbeitete und verbesserte Auflage. Hogrefe, Göttingen Horn W (1983) Leistungsprüfsystem (LPS): Handanweisung. 2. überarbeitete und verbesserte Auflage. Hogrefe, Göttingen
15.
go back to reference Kessler J, Denzler P, Markowitsch HJ (1999) Demenztest. Eine Testbatterie zur Erfassung kognitiver Beeinträchtigungen im Alter. Beltz Test GmbH, Göttingen Kessler J, Denzler P, Markowitsch HJ (1999) Demenztest. Eine Testbatterie zur Erfassung kognitiver Beeinträchtigungen im Alter. Beltz Test GmbH, Göttingen
16.
go back to reference Massie MJ (1990) Depression. In: Holland J, Rowland J (eds) Handbook of psychooncology. Oxford University Press, New York, pp. 283–289 Massie MJ (1990) Depression. In: Holland J, Rowland J (eds) Handbook of psychooncology. Oxford University Press, New York, pp. 283–289
17.
go back to reference Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353PubMed Moffic HS, Paykel ES (1975) Depression in medical in-patients. Br J Psychiatry 126:346–353PubMed
18.
go back to reference Monfardini S, Balducci L (1999) A comprehensive geriatric assessment is necessary for study and management of cancer in the elderly. Eur J Cancer 35:1771–1772CrossRefPubMed Monfardini S, Balducci L (1999) A comprehensive geriatric assessment is necessary for study and management of cancer in the elderly. Eur J Cancer 35:1771–1772CrossRefPubMed
19.
go back to reference Oxman TE, Silberfarb PM (1980) Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 137:1263–1265PubMed Oxman TE, Silberfarb PM (1980) Serial cognitive testing in cancer patients receiving chemotherapy. Am J Psychiatry 137:1263–1265PubMed
20.
go back to reference Rodin G, Voshart K (1986) Depression in the medically ill: An overview. Am J Psychiatry 143:696–705PubMed Rodin G, Voshart K (1986) Depression in the medically ill: An overview. Am J Psychiatry 143:696–705PubMed
21.
go back to reference Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, Rhijn D, Rodenhuis S, van Dam FSAM (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397CrossRefPubMed Schagen SB, Muller MJ, Boogerd W, Rosenbrand RM, Rhijn D, Rodenhuis S, van Dam FSAM (2002) Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol 13:1387–1397CrossRefPubMed
22.
go back to reference Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650CrossRefPubMed Schagen SB, van Dam FSAM, Muller MJ, Boogerd W, Lindeboom J, Bruning PF (1999) Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 85:640–650CrossRefPubMed
23.
go back to reference Silberfarb PM (1983) Chemotherapy and cognitive defects in cancer patients. Annu Rev Med 34:35–46CrossRefPubMed Silberfarb PM (1983) Chemotherapy and cognitive defects in cancer patients. Annu Rev Med 34:35–46CrossRefPubMed
24.
go back to reference Silberfarb PM, Oxman TE (1988) The effects of cancer therapies on the central nervous system. Adv Psychosom Med 18:13–25PubMed Silberfarb PM, Oxman TE (1988) The effects of cancer therapies on the central nervous system. Adv Psychosom Med 18:13–25PubMed
25.
go back to reference Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A (2002) Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychol Psychother 75:165–176CrossRefPubMed Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A (2002) Factor analysis of the hospital anxiety and depression scale from a large cancer population. Psychol Psychother 75:165–176CrossRefPubMed
26.
go back to reference Sturm W, Willmes K (1999) Verbaler Lerntest und Nonverbaler Lerntest (VLT / NVLT). Handanweisung. Hogrefe, Göttingen Sturm W, Willmes K (1999) Verbaler Lerntest und Nonverbaler Lerntest (VLT / NVLT). Handanweisung. Hogrefe, Göttingen
27.
go back to reference Sturm W, Willmes K, Horn W (1993) Leistungsprüfsystem für 50–90jaehrige (LPS 50+). Hogrefe, Göttingen Sturm W, Willmes K, Horn W (1993) Leistungsprüfsystem für 50–90jaehrige (LPS 50+). Hogrefe, Göttingen
28.
go back to reference Taylor BV, Buckner JC, Cascino TL, O‘Fallon JR, Schaefer PL, Dinapoli RP, Schomberg P (1998) Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16:2195–2201PubMed Taylor BV, Buckner JC, Cascino TL, O‘Fallon JR, Schaefer PL, Dinapoli RP, Schomberg P (1998) Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16:2195–2201PubMed
29.
go back to reference Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D (2000) Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 9:29–39CrossRefPubMed Troy L, McFarland K, Littman-Power S, Kelly BJ, Walpole ET, Wyld D, Thomson D (2000) Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology 9:29–39CrossRefPubMed
30.
go back to reference Valente SM, Saunders JM (1996) Diagnosis and treatment of major depression among people with cancer. Cancer Nurs 20:168–177 Valente SM, Saunders JM (1996) Diagnosis and treatment of major depression among people with cancer. Cancer Nurs 20:168–177
31.
go back to reference Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-α therapy. Semin Oncol 25:39–47 Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-α therapy. Semin Oncol 25:39–47
32.
go back to reference Van Dam FSAM, Schagen SB, Muller MJ, Boogerd W, Wall E, Droogleever-Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed Van Dam FSAM, Schagen SB, Muller MJ, Boogerd W, Wall E, Droogleever-Fortuyn ME, Rodenhuis S (1998) Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 90:210–218CrossRefPubMed
33.
go back to reference Wefel JS, Lenzi R, Theriault R, Buzder AU, Cruickshank, S, Meyers CA (2004) Chemobrain in breast cancer? A prologue. Cancer 101:466–475CrossRefPubMed Wefel JS, Lenzi R, Theriault R, Buzder AU, Cruickshank, S, Meyers CA (2004) Chemobrain in breast cancer? A prologue. Cancer 101:466–475CrossRefPubMed
34.
go back to reference Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 14:1457–1462 Wieneke MH, Dienst ER (1995) Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psychooncology 14:1457–1462
Metadata
Title
Medium-term effects of chemotherapy in older cancer patients
Authors
Barbara Eberhardt
Stefan Dilger
Frauke Musial
Ulrich Wedding
Thomas Weiss
Wolfgang H. R. Miltner
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0894-4

Other articles of this Issue 3/2006

Supportive Care in Cancer 3/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine